Investigations

Purdue Pharma's OxyContin (oxycodone extended-release)

How one painkiller's marketing helped ignite the opioid epidemic

The Alzheimer's drug approved against expert advice, priced at $56,000 and withdrawn

A $3.2 million gene therapy, a failed confirmatory trial and deaths from liver failure

The $2.1 million gene therapy, a data manipulation scandal and the price of a cure

An old hormone gel, an 85,000% price increase and Medicare's multibillion-dollar tab

Pricing, marketing, PBM rebates and patent settlements for a rare heart disease drug